Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
824 Views
eMediNexus 05 March 2018
A new article published in Seminars in Dialysis reported that for patients who require hemodialysis, beta blockers offer opportunity as well as challenge in the treatment of cardiovascular disease. This article discussed that beta blockers directly alleviate sympathetic overactivity that links chronic kidney disease with cardiovascular sequelae. The authors stated that trial and observational data can help guide the use of these medications in patients receiving hemodialysis. This review article highlighted the reasons behind considering beta blockers for patients receiving hemodialysis, discussed the barriers to their use, and provided specific evidence-based recommendations for beta blocker use in patients with heart failure, hypertension, ischemic heart disease, and arrhythmia.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}..
Benefits of Resistance Training in Boosting Cardiometabolic Health in .....
Impact of Induction Timing on Maternal and Neonatal Outcomes..
UACR: A Risk Factor for Adverse Cardiovascular Outcomes in Type 2 Diab.....
COPD: A Potential Risk Factor for Herpes Zoster..
FDA Approves LEQSELVI for Severe Alopecia Areata..
{{Article_Title}}..
IMA Warns against 'Mixopathy' While Supporting Alternative Medicine..
Probe Ordered after Govt. Medicines Dumped in J-K's Rajouri..
Anxiety and Relationship Issues Dominate Mental Health Concerns in Delhi: Report..
Suspension of Six Doctors Sparks Strike at Bengal Medical College..
80 cm for Women, 90 cm for Men: New Waist Circumference Standards for Indias Women and Men..